Search Results

Previously, we had identified a novel pyrazole-based agonist 1 ((S)-N-(1-(cyclobutylamino)-1-oxo-5-(piperidin

appears to be a second high-affinity site may simply reflect kinetic factors—such as ligand-receptor-G

treatment of pSS. β-arrestin2 is a key protein that mediates desensitization and internalization of G

Several neurotransmitters and neuromodulators, acting through G-protein-coupled receptors (GPCRs), fine-tune

Methods & Updates in GPCR Research A coiled-coil-based design strategy for the thermostabilization of G-protein-coupled

When the ligand engages the receptor, multiple signaling pathways initiate: G protein activation β-arrestin

μg/L in C. elegans The aim of this study was to identify Gα proteins mediating function of neuronal G

This joint effort by both associations is repeated every year, with 2026’s being in Dublin, Ireland.

GPCR Activation and Signaling β-Arrestin-dependent and -independent endosomal G protein activation by

GPCR Function AlphaFold3 versus experimental structures: assessment of the accuracy in ligand-bound G

GPCRs in Neuroscience Heterotrimeric G proteins regulate planarian regeneration and behavior.

References Brogi, S., Corelli, F., Di Marzo, V., Ligresti, A., Mugnaini, C., Pasquini, S., & Tafi, A.

Source: Way GP, Sailem H, Shave S, Kasprowicz R, Carragher NO. Lin S, Schorpp K, Rothenaigner I, Hadian K. Image-based high-content screening in drug discovery.

These data will be shared as an oral presentation by Ron S.

heterodimer is a potent neutrophil chemoattractant Methods & Updates in GPCR Research GproteinDb in 2024: new G

Upcoming events:  An exclusive preview of the “neuroGPCR: G protein coupled receptor signaling in its

This is a core GPCR pharmacology insight:ligand → receptor → G protein is never the entire story.

G protein-coupled receptor pharmacology - insights from mass spectrometry.

and Exhibition June 2 - 7, 2024 | Chemotactic Cytokines June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein

Small-molecule targeting of GPCR-independent non-canonical G protein signaling inhibits cancer progression

impacting receptor/ligand-binding and signaling patterns, by modulating ligand binding, as well as G-protein

and Exhibition June 2 - 7, 2024 | Chemotactic Cytokines June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein

Here ’s what members get: Weekly deep dives from Dr.

Exendin-4, and possibly through G protein-coupled receptors (GPCRs), increases levels of cAMP and upregulates

It ’s a screening tool, not a substitute for rigorous Schild validation.

This spotlight from Montana Molecular dives into how OPN3’s modulation of MCR4 in appetite circuits and